Home » Reports » Broker Ratings » Dechra Pharmaceuticals plc 12.2% Potential Upside Indicated by HSBC

Dechra Pharmaceuticals plc 12.2% Potential Upside Indicated by HSBC

Dechra Pharmaceuticals plc with EPIC/TICKER (LON:DPH) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at HSBC. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. HSBC have set a target price of 2700 GBX on its stock. This now indicates the analyst believes there is a possible upside of 12.2% from the opening price of 2406 GBX. Over the last 30 and 90 trading days the company share price has increased 6 points and increased 242 points respectively. The 52 week high for the share price is currently at 3180.48 GBX while the 52 week low is 1992 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,399.10 GBX and a 200 day moving average of 2,522.29. There are currently 102,575,157 shares in issue with the average daily volume traded being 270,755. Market capitalisation for LON:DPH is £2,416,670,698 GBP.